SMDP: SARS-CoV-2 Mutation Distribution Profiler for rapid estimation of mutational histories of unusual lineages
Erin E. Gill, Sheri Harari, Aijing Feng, Fiona S.L. Brinkman, Sarah, Otto

TL;DR
SMDP is an open-source web tool that rapidly estimates the mutational history of SARS-CoV-2 lineages by comparing user-submitted mutations with known distributions, aiding public health decision-making.
Contribution
The paper introduces SMDP, a novel web application that quickly infers SARS-CoV-2 lineage histories using mutation distribution comparisons and mutation pattern analysis.
Findings
Accurately classifies mutation distributions for various SARS-CoV-2 lineages.
Detects signs of drug-induced mutagenesis such as molnupiravir exposure.
Provides rapid insights into lineage evolution and mutation rates.
Abstract
SARS-CoV-2 usually evolves at a relatively constant rate over time. Occasionally, however, lineages arise with higher-than-expected numbers of mutations given the date of sampling. Such lineages can arise for a variety of reasons, including selection pressures imposed by evolution during a chronic infection or exposure to mutation-inducing drugs like molnupiravir. We have developed an open-source web-based application (SMDP: SARS-CoV-2 Mutation Distribution Profiler; https://eringill.shinyapps.io/covid_mutation_distributions) that compares a list of user-submitted lineage-defining mutations or a FASTA file containing a single genome (from which lineage-defining mutations are calculated) with established mutation distributions including those observed during (1) the first nine months of the pandemic, (2) during the global transmission of Omicron, (3) during the chronic infection of…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Genomics and Diagnostics · Genomics and Rare Diseases · Bacteriophages and microbial interactions
